|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.08 USD | -3.75% |
|
+1.99% | -44.90% |
| 09/05 | Cantor Fitzgerald Adjusts DocGo Price Target to $5 From $11, Maintains Overweight Rating | MT |
| 09/05 | Deutsche Bank Adjusts DocGo Price Target to $5 From $8.20, Maintains Buy Rating | MT |
Health-care companies rose as a rotation into 2023 laggards continued.
Health-care administrators are investing in digital properties to increase up-take of mail-order pharmaceuticals, The Wall Street Journal reported.
DocGo Chief Executive Lee Bienstock defended the mobile-healthcare company's business model under a controversial migrant-care contract awarded by New York City.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
01-04-24 1725ET
| 1st Jan change | Capi. | |
|---|---|---|
| -44.90% | 313M | |
| -0.66% | 3.09B | |
| 0.00% | 1.97B | |
| +19.18% | 1.79B | |
| +65.37% | 692M | |
| -20.29% | 414M | |
| -21.46% | 170M | |
| -15.15% | 135M | |
| +3.85% | 67.94M |
DOCGO INC. 
